A Safety Study of SGN-2FF for Patients With Advanced Solid Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Christina Derleth, MD
Seagen Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- City of Hope National Medical Center
Duarte, California, United States
- University of Colorado Hospital / University of Colorado
Aurora, Colorado, United States
- Winship Cancer Institute / Emory University School of Medicine
Atlanta, Georgia, United States
- Dana Farber Cancer Institute
Boston, Massachusetts, United States
- Karmanos Cancer Institute / Wayne State University
Detroit, Michigan, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Providence Portland Medical Center
Portland, Oregon, United States
- Sarah Cannon Research Institute
Nashville, Tennessee, United States
- Md Anderson Cancer Center / University of Texas
Houston, Texas, United States
- Seattle Cancer Care Alliance / University of Washington
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 23 Feb 2017
- Primary completion
- 24 Jun 2019
- Completion
- 24 Jun 2019
- Last update posted
- 19 Jul 2019
- Registered enrollment
- 47
- Registry id
- NCT02952989
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.